Literature DB >> 34840657

Therapeutic Effect of Microneedling with Platelet-rich Plasma Versus Microneedling with Tranexamic Acid for Melasma.

Khaled Gharib1, Fawzia Farag Mostafa1, Soheir Ghonemy1.   

Abstract

BACKGROUND: Melasma is a chronic acquired focal pigment disorder showing symmetrical hyperpigmentation or hypermelanosis of photoexposed areas on the face. Tranexamic acid (TXA) is a treatment for melasma. The regression of melasma after platelet-rich-plasma (PRP) treatment is an interesting finding.
OBJECTIVE: We investigated the effect of microneedling followed by PRP versus microneedling followed by tranexamic acid in the treatment of patients with melasma.
METHODS: The study included 26 patients with melasma divided into two groups of 13 patients each. Group 1 was treated with microneedling and PRP, and Group 2 was treated with microneedling and tranexamic acid.
RESULTS: The response to treatment was assessed using the Melasma Area and Severity Index scoring system before and after treatment. At the start of the study and at the first session, there were no statistically significant differences (p>0.05). At the second and third treatment sessions, there were statistically significant differences (p<0.05). There were no statistically significant differences between the two groups regarding side effects of pain, erythema and postinflammatory hyperpigmentation.
CONCLUSION: Microneedling with PRP offers better results than microneedling with TXA in treating melasma.
Copyright © 2021. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Melasma; microneedling; platelet-rich-plasma; tranexamic acid

Year:  2021        PMID: 34840657      PMCID: PMC8570658     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  16 in total

Review 1.  Platelet-rich plasma in dermatology: boon or a bane?

Authors:  M Sendhil Kumaran
Journal:  Indian J Dermatol Venereol Leprol       Date:  2014 Jan-Feb       Impact factor: 2.545

2.  Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women.

Authors:  A de A Tamega; L D B Miot; C Bonfietti; T C Gige; M E A Marques; H A Miot
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-01-03       Impact factor: 6.166

Review 3.  Oral Tranexamic Acid for the Treatment of Melasma: A Review.

Authors:  Harini R Bala; Senhong Lee; Celestine Wong; Amit G Pandya; Michelle Rodrigues
Journal:  Dermatol Surg       Date:  2018-06       Impact factor: 3.398

Review 4.  Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.

Authors:  Hyun Jung Kim; Seok Hoon Moon; Sang Hyun Cho; Jeong Deuk Lee; Hei Sung Kim
Journal:  Acta Derm Venereol       Date:  2017-07-06       Impact factor: 4.437

5.  Efficacy and possible mechanisms of topical tranexamic acid in melasma.

Authors:  S J Kim; J-Y Park; T Shibata; R Fujiwara; H Y Kang
Journal:  Clin Exp Dermatol       Date:  2016-05-02       Impact factor: 3.470

6.  Epidemiology of melasma in Brazilian patients: a multicenter study.

Authors:  Doris Hexsel; Davi A Lacerda; Andrea S Cavalcante; Carlos A S Machado Filho; Célia Luiza P V Kalil; Eloísa L Ayres; Luna Azulay-Abulafia; Magda B Weber; Marcio S Serra; Nádya F P Lopes; Tania F Cestari
Journal:  Int J Dermatol       Date:  2013-08-22       Impact factor: 2.736

7.  Platelet-rich plasma is a useful therapeutic option in melasma.

Authors:  Eman R M Hofny; Amira A Abdel-Motaleb; Alaa Ghazally; Asmaa Mahmoud Ahmed; Mahmoud Rezk Abdelwahed Hussein
Journal:  J Dermatolog Treat       Date:  2018-11-29       Impact factor: 3.359

8.  A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma.

Authors:  Leelavathy Budamakuntla; Eswari Loganathan; Deepak Hurkudli Suresh; Sharavana Shanmugam; Shwetha Suryanarayan; Aparna Dongare; Lakshmi Dammaningala Venkataramiah; Namitha Prabhu
Journal:  J Cutan Aesthet Surg       Date:  2013-07

9.  Regression of melasma with platelet-rich plasma treatment.

Authors:  Mutlu Cayırlı; Ercan Calışkan; Gürol Açıkgöz; Ahmet Hakan Erbil; Güneş Ertürk
Journal:  Ann Dermatol       Date:  2014-06-12       Impact factor: 1.444

10.  A Randomized Controlled Study Comparing the Efficacy of Topical 5% Tranexamic Acid Solution versus 3% Hydroquinone Cream in Melasma.

Authors:  Manasa S Janney; Radhakrishnan Subramaniyan; Rajeshwari Dabas; Sandeep Lal; Niyor M Das; Satish K Godara
Journal:  J Cutan Aesthet Surg       Date:  2019 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.